KDM4A
MOLECULAR TARGETlysine demethylase 4A
KDM4A (lysine demethylase 4A) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KDM4A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | deferiprone | 3.81 | 44 |
| 2 | n oxalylglycine | 3.43 | 30 |
| 3 | bispyrrolidinylthiocarbonyldisulfide | 1.95 | 6 |
| 4 | Deferasirox | 1.39 | 3 |
| 5 | Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as | 1.10 | 2 |
About KDM4A as a Drug Target
KDM4A (lysine demethylase 4A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented KDM4A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KDM4A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.